We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+16.47%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.6B
AUM Growth
+$842M
Cap. Flow
-$440M
Cap. Flow %
-4.14%
Top 10 Hldgs %
16.26%
Holding
2,304
New
726
Increased
425
Reduced
494
Closed
615

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$240M
2
TMO icon
Thermo Fisher Scientific
TMO
+$151M
3
BSX icon
Boston Scientific
BSX
+$121M
4
AMZN icon
Amazon
AMZN
+$104M
5
TRU icon
TransUnion
TRU
+$81M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.87%
2 Healthcare 20.58%
3 Financials 10.9%
4 Technology 10.13%
5 Industrials 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGYS icon
1301
Agilysys
AGYS
$2.94B
$243K ﹤0.01%
+11,473
New +$212K
EWU icon
1302
iShares MSCI United Kingdom ETF
EWU
$4.07B
$241K ﹤0.01%
+7,307
New +$233K
GSBC icon
1303
Great Southern Bancorp
GSBC
$865M
$241K ﹤0.01%
+4,634
New +$246K
IRMD icon
1304
iRadimed
IRMD
$1.23B
$241K ﹤0.01%
+8,597
New +$225K
ARC
1305
DELISTED
ARC Document Solutions, Inc.
ARC
$239K ﹤0.01%
107,248
-67,489
-39% -$165K
CECO icon
1306
Ceco Environmental
CECO
$4.31B
$233K ﹤0.01%
+32,306
New +$234K
CIC.WS
1307
DELISTED
Capitol Investment Corp. IV
CIC.WS
$230K ﹤0.01%
166,665
NGS icon
1308
Natural Gas Services Group
NGS
$470M
$229K ﹤0.01%
+13,231
New +$236K
THO icon
1309
Thor Industries
THO
$4.09B
$229K ﹤0.01%
3,674
-27,643
-88% -$1.75M
RARX
1310
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$229K ﹤0.01%
+10,225
New +$220K
TWTR
1311
DELISTED
Twitter, Inc.
TWTR
$228K ﹤0.01%
6,948
-15,406
-69% -$488K
FSBW icon
1312
FS Bancorp
FSBW
$324M
$227K ﹤0.01%
8,976
-4,558
-34% -$113K
RVTY icon
1313
Revvity
RVTY
$12.2B
$227K ﹤0.01%
2,359
-6,790
-74% -$612K
ASTH icon
1314
Astrana Health
ASTH
$1.95B
$224K ﹤0.01%
12,201
-24,353
-67% -$467K
MTEM
1315
DELISTED
Molecular Templates, Inc.
MTEM
$224K ﹤0.01%
2,566
+928
+57% +$68K
KBE icon
1316
State Street SPDR S&P Bank ETF
KBE
$1.64B
$222K ﹤0.01%
+5,315
New +$228K
OXSQ icon
1317
Oxford Square Capital
OXSQ
$155M
$222K ﹤0.01%
+34,201
New +$226K
ARNA
1318
DELISTED
Arena Pharmaceuticals Inc
ARNA
$222K ﹤0.01%
4,950
-79,737
-94% -$3.66M
BGSF icon
1319
BGSF Inc
BGSF
$57M
$220K ﹤0.01%
+10,081
New +$242K
SHAK icon
1320
Shake Shack
SHAK
$2.4B
$219K ﹤0.01%
3,701
-203,811
-98% -$10.4M
WLY icon
1321
John Wiley & Sons Class A
WLY
$2.59B
$218K ﹤0.01%
4,917
-1,639
-25% -$80.4K
FXE icon
1322
PUT
Invesco CurrencyShares Euro Currency Trust
FXE
$341M
$213K ﹤0.01%
+2,000
New +$217K
FCOM icon
1323
Fidelity MSCI Communication Services Index ETF
FCOM
$1.78B
$212K ﹤0.01%
+6,648
New +$208K
MCB icon
1324
Metropolitan Bank Holding Corp
MCB
$1.13B
$211K ﹤0.01%
6,059
+4,655
+332% +$166K
AMWD
1325
DELISTED
American Woodmark
AMWD
$209K ﹤0.01%
2,536
-79,638
-97% -$5.95M

Similar funds

Marshall Wace's Q1 2019 Portfolio in Review

As of Q1 2019, Marshall Wace held 2,304 positions worth $10.6B, up 8.6% from $9.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace withdrew a net $440M in Q1 2019, closing 615 positions and reducing 494 holdings. Its most notable exit was Shire pic, an estimated $166M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Marshall Wace opened a new position in TransUnion worth $87.4M.

  • Marshall Wace's largest Q1 2019 buy was TransUnion: 1,307,679 shares worth $87.4M.
  • Marshall Wace added most to McDonald's in Q1 2019, an estimated $240M increase.
  • Marshall Wace's biggest Q1 2019 reduction was Alphabet (Google) Class A, cutting an estimated $132M.
  • Marshall Wace fully exited Shire pic in Q1 2019, selling an estimated $166M.
  • Marshall Wace's ten largest holdings make up 16% of its $10.6B portfolio in Q1 2019.
  • Marshall Wace opened 726 new positions and closed 615 in Q1 2019.
  • Marshall Wace's portfolio value rose 8.6% quarter-over-quarter to $10.6B.

Based on Marshall Wace's 13F filing for Q1 2019, filed 14 May 2019.